Przemysław Jurczak
Przemysław Jurczak
Wydział Chemii, Uniwersytet Gdański
Verified email at ug.edu.pl
TitleCited byYear
Evaluating the toxicity of TiO2-based nanoparticles to Chinese hamster ovary cells and Escherichia coli: a complementary experimental and computational approach
A Mikolajczyk, N Sizochenko, E Mulkiewicz, A Malankowska, M Nischk, ...
Beilstein journal of nanotechnology 8 (1), 2171-2180, 2017
142017
Human cystatin C monomer, dimer, oligomer, and amyloid structures are related to health and disease
P Jurczak, P Groves, A Szymanska, S Rodziewicz‐Motowidlo
FEBS letters 590 (23), 4192-4201, 2016
122016
Proteins, peptides and peptidomimetics as active agents in implant surface functionalization
P Jurczak, J Witkowska, S Rodziewicz-Motowidlo, S Lach
Advances in Colloid and Interface Science, 102083, 2019
2019
NMR and crystallographic structural studies of the extremely stable monomeric variant of human cystatin C with single amino acid substitution
M Maszota‐Zieleniak, P Jurczak, M Orlikowska, I Zhukov, D Borek, ...
The FEBS journal, 2019
2019
Structural analysis and molecular dynamic processes in the human cystatin C at presence of human serum albumin (HSA) by means NMR spectroscopy
I Zhukov, A Szymanska, P Jurczak, W Bal, M Kozak
FEBS OPEN BIO 9, 277-278, 2019
2019
Studies on the Influence of Protein-ligand and Protein-cell Membrane Interactions on the Amyloidogenic Protein Oligomerization Process: the Case of Human Cystatin C
P Jurczak
2019
Human cystatin C V57G mutant–nuclear magnetic resonance studies
M Maszota-Zieleniak, P Jurczak, A Szymańska, P Skowron, I Zhukov, ...
JOURNAL OF PEPTIDE SCIENCE 22, S214-S216, 2016
2016
NMR STUDIES OF HUMAN CYSTATIN C–STABLE ISOTOPE LABELING OF HUMAN CYSTATIN C
P Jurczak, M Maszota-Zieleniak
Task Quarterly 18 (4), 327-330, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–8